干细胞中的黑色素和血管生成潜力
Somayyeh Rashidi1, Sara Aghakhani Chegeni2, Golbarg Roozbahani3
1Department of Medical Biotechnology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Stem cell research & therapy
|August 5, 2025
概括
黑素 (mel) 可能增强干细胞驱动的血管形成 (血管生成),以治疗缺血性心脏病. 这项研究回顾了梅尔如何影响潜在新疗法的干细胞行为.
科学领域:
- 再生医学是一种再生医学.
- 心血管研究研究心血管研究
- 分子生物学分子生物学
背景情况:
- 缺血性心脏病,包括心肌梗塞,是导致死亡的主要原因,尽管进行了干预,但往往导致慢性心力衰竭.
- 血管新生,即新血管的形成,对于恢复缺血组织的血液 perfusion 和预防疾病进展至关重要.
- 干细胞通过分化或膜信号提供治疗潜力,但它们的血管新生调节需要进一步了解.
研究的目的:
- 评估当前有关黑激素 (mel) 如何影响干细胞的血管性质的数据.
- 探索黑激素作为治疗缺血病的再生医学辅助疗法的潜力.
主要方法:
- 系统审查和评估现有的科学文献.
- 对调查黑激素对干细胞介导血管生成的影响的研究分析.
主要成果:
- 黑色素表现出性作用,包括抗氧化,抗炎和潜在的益血管效应.
- 有证据表明,黑激素可能调节干细胞行为以促进血管生成,尽管机制正在调查中.
- 该审查巩固了有关黑激素在干细胞治疗缺血症中的作用的发现.
结论:
- 黑素在增强干细胞驱动的血管生成方面显示出有前途,用于治疗缺血性疾病.
- 对黑激素对干细胞作用机制的进一步研究可能会导致针对心力衰竭和其他缺血病理的新疗法策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mechanism of Angiogenesis
5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K


